Company news

Korro Bio, Inc. news in 2023

Korro Bio, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Korro Announces Selection of its First Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

December 6, 2023

Korro Bio Appoints Dr. Rachel Meyers to Board of Directors

November 27, 2023

Frequency Therapeutics Provides Business Updates and Second Quarter 2023 Financial Results

August 9, 2023

Korro Bio and Frequency Therapeutics Announce Merger Agreement

July 13, 2023

Frequency Therapeutics Provides Business Updates and First Quarter 2023 Financial Results

May 11, 2023

Frequency Therapeutics Provides Business Updates and Fourth Quarter and Full Year 2022 Financial Results

March 9, 2023

Frequency Therapeutics to Participate at Upcoming March Investor Conferences

February 26, 2023

Frequency Therapeutics Announces Topline Results for its Phase 2b Study of FX-322 for the Treatment of Sensorineural Hearing Loss

February 12, 2023

Decks in 2023